Response Biomedical expands distribution of cardiovascular products in the U.S.

Vancouver's Response Biomedical Corp. (TSC: RBM) (OTCBB: RPBIF) has entered into a distribution agreement with Laboratory Supply Company, Inc. (LABSCO) in Louisville, Kentucky, to distribute ...

Vancouver's Response Biomedical Corp. (TSC: RBM) (OTCBB: RPBIF) has entered into a distribution agreement with Laboratory Supply Company, Inc. (LABSCO) in Louisville, Kentucky, to distribute cardiovascular products in the U.S. to hospitals with fewer than 150 beds.

LABSCO is the largest privately held distributor of clinical lab products in the U.S.

"This is a very important agreement for Response as it marks a significant step into the U.S. market for POCT [point-of-care testing] in the cardiovascular areana, which is one of the largest markets in the world," said Tim Shannon, Response Biomedical Corp.'s senior vice-president of worldwide sales and marketing.

"LABSCO has the experience and reputation to maximize our efforts to gain traction and to help us penetrate a market that we believe will greatly enhance our growth in the near term and beyond."

The POCT market in the U.S. is worth an estimated $3.1 billion.

ecrawford@biv.com

@EmmaCrawfordBIV

comments powered by Disqus

Also Read

More From Innovation

As Vancouver’s Westport Innovations (NASDAQ:WPRT) cuts jobs and salaries, the CEO of the natural gas engine manufacturer is hoping for growth in the coming year ...

Read Article

BioLytical Laboratories, the Richmond biotech best known for its 60-second HIV test, has developed ...

Read Article

As Toronto TV production companies are partnering with digital platform services, local digital producers still struggle to score a runaway success 

Read Article

Just US$1 billion in venture capital funding was invested in Canada last year compared with $US33.1 billion in the U.S. 

Read Article

Sixty million beacon devices are expected to ship by 2019 as startups and corporations rush to service emerging market 

Read Article

Subscribe to our mailing lists

* indicates required

Newsletters

* You can modify your newsletter subscriptions at the bottom of any newsletter you receive.
×